-
Why the Democrats’ US election victory is a win for investorsThe Democrats' sweep in the US elections was seen by investors in East Asia as a clear rejection of AI. But more red tape may still not burst the AI bubble
-
Most popular investments: What did private investors buy in October?Money market funds continued their upbeat streak as investors sought stability in a volatile world, while space-themed funds and stocks remained popular.
-
“Follow the Money”: Stephen Yiu’s strategy for the AI eraFollowing the money across the three sources of spending – consumer, business, and government – Blue Whale Growth Fund manager Stephen Yiu shares his strategy.
-
The IPO catch: Why the best deals are often the hardest to buy intoUK investors can now apply for the biggest US flotations. Miss out and buy once trading starts, and history suggests you'll do no better than the market, while carrying one company's risk.
-
Tech selloff: are AI spending concerns justified?Investors are growing increasingly anxious about AI spending amid the hyperscalers, as disappointing earnings reports wipe trillions of dollars off market values.
-
Three top-class smaller biotechnology companiesOpinion Three smaller biotechnology companies with big potential, picked by Geoffrey Hsu, managing partner at OrbiMed and portfolio manager of the Biotech Growth Trust.
Opinion -
The extraordinary rise of Sea Limited, Asia's online marketplaceAsian online shopping company Sea Limited is well placed to recover from recent disasters. Is it time to buy its shares?
-
The nuclear industry is set to melt up – here’s what to buyOpinion Some of the nuclear industry’s first-rate firms are being ditched by distressed sellers. Nick Lawson explains why you should snap them up
Opinion -
Consumer brands are in the bargain bin – how to investPowerful consumer brands can deliver long-term value, but it's not a one-way bet. Here are the products offering the best value for shareholders
